Why It Matters
Products may differ in formulation and testing, while key studies do not establish an optimal dose or universal benefit.
Urolithin A has mixed human evidence: some secondary endurance, strength and biomarker findings were favorable, while primary performance outcomes were not significant in two sponsor-linked trials (PMID:35050355; PMID:35584623). A review found no effects on anthropometrics, cardiovascular outcomes or physical function, and a small athlete trial found no significant strength improvement (PMID:39002645; PMID:39487653).
At a glance
Common questions about Urolithin A answered by our experts